Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cytosolic galectin-7 impairs p53 functions and induces chemoresistance in breast cancer cells.

BMC cancer - 3 Nov 2014

Grosset Andrée-Anne, Labrie Marilyne, Gagné Donald, Vladoiu Maria-Claudia, Gaboury Louis, Doucet Nicolas, St-Pierre Yves

Abstract excerpt

BACKGROUND: Resistance to apoptosis induced by anti-cancer drugs is a major obstacle for the treatment of aggressive forms of breast cancer. Galectin-7 (gal-7) was recently shown to be specifically expressed in basal-like but not in luminal subtypes of human breast cancer. METHODS: We generated a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance, Neoplasm
Share to Galectins
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Intracellular Space

Share to Protein Conformation

Share to Protein Transport

Share to Proto-Oncogene Proteins p21(ras)

Share to Tumor Suppressor Protein p53

Source

Open in PubMed Open full text

Identifiers

PMID: 25367122
DOI: 10.1186/1471-2407-14-801
PMCID: PMC4228062

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25367122-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cytosolic galectin-7 impairs p53 functions and induces chemoresistance in breast cancer cells.PMID 25367122Read ↗

A Mutation in the Carbohydrate Recognition Domain Drives a Phenotypic Switch in the Role of Galectin-7 in Prostate Cancer.Semantic proximity Read ↗

Expression of galectin-7 is induced in breast cancer cells by mutant p53.Semantic proximity Read ↗

Mitochondrial proteomic approach reveals galectin-7 as a novel BCL-2 binding protein in human cellsSemantic proximity Read ↗

Growth-regulatory human galectin-1: crystallographic characterisation of the structural changes induced by single-site mutations and their impact on the thermodynamics of ligand binding.Semantic proximity Read ↗

P7 antigen expression in human breast cancer.Semantic proximity Read ↗

Galectin-3 germline variant at position 191 enhances nuclear accumulation and activation of β-catenin in gastric cancer.Semantic proximity Read ↗

Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest.Semantic proximity Read ↗

It depends on the hinge: a structure-functional analysis of galectin-8, a tandem-repeat type lectin.Semantic proximity Read ↗

Ivermectin inhibits HSP27 and potentiates efficacy of oncogene targeting in tumor modelsSemantic proximity Read ↗

Targeting oncogenic interleukin-7 receptor signalling with N-acetylcysteine in T cell acute lymphoblastic leukaemia.Semantic proximity Read ↗

A galectin-3 sequence polymorphism confers TRAIL sensitivity to human breast cancer cells.Semantic proximity Read ↗

Galectin-13, a different prototype galectin, does not bind β-galacto-sides and forms dimers via intermolecular disulfide bridges between Cys-136 and Cys-138.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.